These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 15897607

  • 1. Macrophage-specific expression of group IIA sPLA2 results in accelerated atherogenesis by increasing oxidative stress.
    Tietge UJ, Pratico D, Ding T, Funk CD, Hildebrand RB, Van Berkel T, Van Eck M.
    J Lipid Res; 2005 Aug; 46(8):1604-14. PubMed ID: 15897607
    [Abstract] [Full Text] [Related]

  • 2. Macrophage-specific overexpression of group IIa sPLA2 increases atherosclerosis and enhances collagen deposition.
    Ghesquiere SA, Gijbels MJ, Anthonsen M, van Gorp PJ, van der Made I, Johansen B, Hofker MH, de Winther MP.
    J Lipid Res; 2005 Feb; 46(2):201-10. PubMed ID: 15576846
    [Abstract] [Full Text] [Related]

  • 3. Hawthorn leaf flavonoids alleviate the deterioration of atherosclerosis by inhibiting SCAP-SREBP2-LDLR pathway through sPLA2-ⅡA signaling in macrophages in mice.
    Bai X, Wang S, Shu L, Cao Q, Hu H, Zhu Y, Chen C.
    J Ethnopharmacol; 2024 Jun 12; 327():118006. PubMed ID: 38442806
    [Abstract] [Full Text] [Related]

  • 4. Role of group II secretory phospholipase A2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipids.
    Leitinger N, Watson AD, Hama SY, Ivandic B, Qiao JH, Huber J, Faull KF, Grass DS, Navab M, Fogelman AM, de Beer FC, Lusis AJ, Berliner JA.
    Arterioscler Thromb Vasc Biol; 1999 May 12; 19(5):1291-8. PubMed ID: 10323782
    [Abstract] [Full Text] [Related]

  • 5. Potent modification of low density lipoprotein by group X secretory phospholipase A2 is linked to macrophage foam cell formation.
    Hanasaki K, Yamada K, Yamamoto S, Ishimoto Y, Saiga A, Ono T, Ikeda M, Notoya M, Kamitani S, Arita H.
    J Biol Chem; 2002 Aug 09; 277(32):29116-24. PubMed ID: 12021277
    [Abstract] [Full Text] [Related]

  • 6. Macrophage sortilin promotes LDL uptake, foam cell formation, and atherosclerosis.
    Patel KM, Strong A, Tohyama J, Jin X, Morales CR, Billheimer J, Millar J, Kruth H, Rader DJ.
    Circ Res; 2015 Feb 27; 116(5):789-96. PubMed ID: 25593281
    [Abstract] [Full Text] [Related]

  • 7. Macrophage-expressed group IIA secretory phospholipase A2 increases atherosclerotic lesion formation in LDL receptor-deficient mice.
    Webb NR, Bostrom MA, Szilvassy SJ, van der Westhuyzen DR, Daugherty A, de Beer FC.
    Arterioscler Thromb Vasc Biol; 2003 Feb 01; 23(2):263-8. PubMed ID: 12588769
    [Abstract] [Full Text] [Related]

  • 8. Group v secretory phospholipase A2 promotes atherosclerosis: evidence from genetically altered mice.
    Bostrom MA, Boyanovsky BB, Jordan CT, Wadsworth MP, Taatjes DJ, de Beer FC, Webb NR.
    Arterioscler Thromb Vasc Biol; 2007 Mar 01; 27(3):600-6. PubMed ID: 17204667
    [Abstract] [Full Text] [Related]

  • 9. Group V secretory phospholipase A2-modified low density lipoprotein promotes foam cell formation by a SR-A- and CD36-independent process that involves cellular proteoglycans.
    Boyanovsky BB, van der Westhuyzen DR, Webb NR.
    J Biol Chem; 2005 Sep 23; 280(38):32746-52. PubMed ID: 16040605
    [Abstract] [Full Text] [Related]

  • 10. Increased hepatic cholesterol accumulation in transgenic mice overexpressing human secretory phospholipase A2 group IIA.
    Eckey R, Menschikowski M, Lattke P, Jaross W.
    Inflammation; 2004 Apr 23; 28(2):59-65. PubMed ID: 15379211
    [Abstract] [Full Text] [Related]

  • 11. Expression of type IIA secretory phospholipase A2 inhibits cholesteryl ester transfer protein activity in transgenic mice.
    Hurt-Camejo E, Gautier T, Rosengren B, Dikkers A, Behrendt M, Grass DS, Rader DJ, Tietge UJ.
    Arterioscler Thromb Vasc Biol; 2013 Dec 23; 33(12):2707-14. PubMed ID: 24115030
    [Abstract] [Full Text] [Related]

  • 12. Human secretory phospholipase A2 mediates decreased plasma levels of HDL cholesterol and apoA-I in response to inflammation in human apoA-I transgenic mice.
    Tietge UJ, Maugeais C, Lund-Katz S, Grass D, deBeer FC, Rader DJ.
    Arterioscler Thromb Vasc Biol; 2002 Jul 01; 22(7):1213-8. PubMed ID: 12117740
    [Abstract] [Full Text] [Related]

  • 13. Effect of bone marrow transplantation on lipoprotein metabolism and atherosclerosis in LDL receptor-knockout mice.
    Herijgers N, Van Eck M, Groot PH, Hoogerbrugge PM, Van Berkel TJ.
    Arterioscler Thromb Vasc Biol; 1997 Oct 01; 17(10):1995-2003. PubMed ID: 9351364
    [Abstract] [Full Text] [Related]

  • 14. Effect of human scavenger receptor class A overexpression in bone marrow-derived cells on lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knockout mice.
    Herijgers N, de Winther MP, Van Eck M, Havekes LM, Hofker MH, Hoogerbrugge PM, Van Berkel TJ.
    J Lipid Res; 2000 Sep 01; 41(9):1402-9. PubMed ID: 10974047
    [Abstract] [Full Text] [Related]

  • 15. Macrophage Lxrα reduces atherosclerosis in Ldlr-/- mice independent of Arl7 transactivation.
    Yin Y, Zeng S, Li Y, Wu Z, Huang D, Gao P.
    Biochem Biophys Res Commun; 2020 Aug 27; 529(3):540-547. PubMed ID: 32736671
    [Abstract] [Full Text] [Related]

  • 16. Secretory phospholipase A2 group V: lesion distribution, activation by arterial proteoglycans, and induction in aorta by a Western diet.
    Rosengren B, Peilot H, Umaerus M, Jönsson-Rylander AC, Mattsson-Hultén L, Hallberg C, Cronet P, Rodriguez-Lee M, Hurt-Camejo E.
    Arterioscler Thromb Vasc Biol; 2006 Jul 27; 26(7):1579-85. PubMed ID: 16601231
    [Abstract] [Full Text] [Related]

  • 17. Modulation of lipid profile by secretory phospholipase A2 group IIA: Verification with a transgenic mouse model.
    Liang L, Song J, Miao S, Xie Q, Li W, Huang H, Shen D, Zhang W.
    Biochem Biophys Res Commun; 2024 Jun 18; 712-713():149955. PubMed ID: 38640737
    [Abstract] [Full Text] [Related]

  • 18. Role of group II secretory phospholipase A2 in atherosclerosis: 1. Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2.
    Ivandic B, Castellani LW, Wang XP, Qiao JH, Mehrabian M, Navab M, Fogelman AM, Grass DS, Swanson ME, de Beer MC, de Beer F, Lusis AJ.
    Arterioscler Thromb Vasc Biol; 1999 May 18; 19(5):1284-90. PubMed ID: 10323781
    [Abstract] [Full Text] [Related]

  • 19. Activated platelets contribute to oxidized low-density lipoproteins and dysfunctional high-density lipoproteins through a phospholipase A2-dependent mechanism.
    Blache D, Gautier T, Tietge UJ, Lagrost L.
    FASEB J; 2012 Feb 18; 26(2):927-37. PubMed ID: 22042222
    [Abstract] [Full Text] [Related]

  • 20. Low density lipoprotein receptor of macrophages facilitates atherosclerotic lesion formation in C57Bl/6 mice.
    Herijgers N, Van Eck M, Groot PH, Hoogerbrugge PM, Van Berkel TJ.
    Arterioscler Thromb Vasc Biol; 2000 Aug 18; 20(8):1961-7. PubMed ID: 10938018
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.